Slava Akmaev Speaks at ‘Artificial Intelligence in Bioscience Symposium’ in London

Slava Akmaev, BERG’s Chief Analytics Officer, speaks about artificial intelligence in biopharmaceutical research and development at The British Library in London on Sept. 14, 2017. The talk will focus on practical applications of Bayesian Artificial Intelligence in drug discovery and clinical development. The AI-informed discovery process provides an unbiased alternative approach to the more traditional[…]

BERG Analytics at HIMSS17

BERG Analytics will be exhibiting at HIMSS 17 , February 19th – 23rd at the Orange County Convention Center in Orlando Florida. Join us at booth #5584 and stop by to find out more about BERG Analytics’ bAIcis platform and our healthcare analytics solutions. http://www.himssconference.org/

HIt Consultant

BD Taps BERG’s AI Platform to Reduce Medication Non-Adherence

HIT Consultant has published an article on BERG Analytics multi-year commercial agreement with Becton Dickinson to apply our AI platform bAIcis™ in order to provide deep analysis of the BD/MedMined hospital data with the objective of discovering new patterns and risk factors of patient medication non-compliance. The full article can be viewed here:  http://hitconsultant.net/2017/01/12/bd-berg-health-partnership/

Artificial Intelligence in Medicine Journal Publishes BERG Analytics Research

Non-obvious correlations to disease management unraveled by Bayesian artificial intelligence analyses of CMS data Artificial Intelligence in Medicine 2016, Vemulapalli et al. – bAIcis™, the Interrogative Biology® AI engine discovers a novel link between use of asthma medications and renal insufficiency Bayesian networks are powerful mathematical frameworks for learning probable cause and effect relationships from[…]